Fajian He
Overview
Explore the profile of Fajian He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He F, Gong Y, Tao G, Zhang J, Wu Q, Tan Y, et al.
Cancer Commun (Lond)
. 2024 Oct;
44(12):1391-1413.
PMID: 39402748
Background: Immunotherapy has revolutionized the therapeutical regimen for nasopharyngeal carcinoma (NPC), yet its response rate remains insufficient. Programmed death-ligand 1 (PD-L1) on small extracellular vesicles (sEVs) mediates local and peripheral...
2.
Zhang J, Li Y, Dai W, Tang F, Wang L, Wang Z, et al.
Cancer Immunol Immunother
. 2024 Mar;
73(4):71.
PMID: 38430394
Background: Due to individual differences in tumors and immune systems, the response rate to immunotherapy is low in lung adenocarcinoma (LUAD) patients. Combinations with other therapeutic strategies improve the efficacy...
3.
Zhu Q, Jiang F, Song Y, Lu L, He F, Huang S, et al.
J Toxicol Sci
. 2023 Oct;
48(10):535-546.
PMID: 37778982
The accumulation of excessively high manganese levels within the brain can contribute to a series of Parkinsonian symptoms referred to as manganism. The gasoline antiknock additive Methylcyclopentadienyl Manganese Tricarbonyl (MMT)...
4.
Zeng Z, Gao Y, Li J, Zhang J, Li Y, He F, et al.
Genes Dis
. 2023 May;
10(2):336-339.
PMID: 37223520
No abstract available.
5.
Li R, Qiu T, Zhou Q, He F, Jie C, Zheng X, et al.
Front Immunol
. 2023 Apr;
14:1139599.
PMID: 37006256
Background: Histone acetylation-related lncRNAs (HARlncRNAs) play significant roles in various cancers, but their impact on lung adenocarcinoma (LUAD) remains unclear. This study aimed to develop a new HARlncRNA-based prognostic model...
6.
Xie H, Liu X, Huang Z, Xu L, Bai R, He F, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010926
Cancer severely threatens human health and has remained the leading cause of disease-related death for decades. With the rapid advancement of nanomedicine, nanoscale metal-organic frameworks are believed to be potentially...
7.
Bai R, Zhang J, He F, Li Y, Dai P, Huang Z, et al.
Commun Biol
. 2022 Jul;
5(1):663.
PMID: 35790819
The purpose of this study is to examine the association between G protein-coupled receptor 87 (GPR87) and lung adenocarcinoma (LUAD) metastasis and immune infiltration. The Cancer Genome Atlas (TCGA) and...
8.
Dai W, Zhang J, Li S, He F, Liu Q, Gong J, et al.
Front Immunol
. 2022 May;
13:865964.
PMID: 35493527
In recent years, protein arginine methyltransferases (PRMTs) have emerged as new members of a gene expression regulator family in eukaryotes, and are associated with cancer pathogenesis and progression. Cancer immunotherapy...
9.
Gao Y, Zhang N, Zeng Z, Wu Q, Jiang X, Li S, et al.
Clin Transl Med
. 2022 Apr;
12(4):e792.
PMID: 35415876
Background: The expression of long non-coding RNA (lncRNA) prostate cancer-associated ncRNA transcripts 1 (PCAT1) is increased in non-small cell lung cancer (NSCLC). It stimulates tumour growth and metastasis, but its...
10.
Huang F, Thokerunga E, He F, Zhu X, Wang Z, Tu J
Stem Cell Res Ther
. 2022 Jan;
13(1):1.
PMID: 34998430
Chronic inflammatory systemic diseases are the result of the body's immune imbalance, with a long course and recurring episodes. Immunosuppressants are the main treatment, but not all patients respond well...